213 related articles for article (PubMed ID: 22919057)
1. Role of TSH in the spontaneous development of asymmetrical thyroid carcinoma in mice with a targeted mutation in a single allele of the thyroid hormone-β receptor.
Zhao L; Zhu X; Won Park J; Fozzatti L; Willingham M; Cheng SY
Endocrinology; 2012 Oct; 153(10):5090-100. PubMed ID: 22919057
[TBL] [Abstract][Full Text] [Related]
2. Activation of tumor cell proliferation by thyroid hormone in a mouse model of follicular thyroid carcinoma.
Lu C; Zhu X; Willingham MC; Cheng SY
Oncogene; 2012 Apr; 31(16):2007-16. PubMed ID: 21909131
[TBL] [Abstract][Full Text] [Related]
3. Growth activation alone is not sufficient to cause metastatic thyroid cancer in a mouse model of follicular thyroid carcinoma.
Lu C; Zhao L; Ying H; Willingham MC; Cheng SY
Endocrinology; 2010 Apr; 151(4):1929-39. PubMed ID: 20133453
[TBL] [Abstract][Full Text] [Related]
4. Synergistic signaling of KRAS and thyroid hormone receptor β mutants promotes undifferentiated thyroid cancer through MYC up-regulation.
Zhu X; Zhao L; Park JW; Willingham MC; Cheng SY
Neoplasia; 2014 Sep; 16(9):757-69. PubMed ID: 25246276
[TBL] [Abstract][Full Text] [Related]
5. Diet-induced obesity increases tumor growth and promotes anaplastic change in thyroid cancer in a mouse model.
Kim WG; Park JW; Willingham MC; Cheng SY
Endocrinology; 2013 Aug; 154(8):2936-47. PubMed ID: 23748362
[TBL] [Abstract][Full Text] [Related]
6. Genomic profiling of genes contributing to metastasis in a mouse model of thyroid follicular carcinoma.
Lu C; Mishra A; Zhu YJ; Meltzer P; Cheng SY
Am J Cancer Res; 2011 Jan; 1(1):1-13. PubMed ID: 21562609
[TBL] [Abstract][Full Text] [Related]
7. Mutation of thyroid hormone receptor-β in mice predisposes to the development of mammary tumors.
Guigon CJ; Kim DW; Willingham MC; Cheng SY
Oncogene; 2011 Jul; 30(30):3381-90. PubMed ID: 21399657
[TBL] [Abstract][Full Text] [Related]
8. Knock-in mouse model for resistance to thyroid hormone (RTH): an RTH mutation in the thyroid hormone receptor beta gene disrupts cochlear morphogenesis.
Griffith AJ; Szymko YM; Kaneshige M; Quiñónez RE; Kaneshige K; Heintz KA; Mastroianni MA; Kelley MW; Cheng SY
J Assoc Res Otolaryngol; 2002 Sep; 3(3):279-88. PubMed ID: 12382103
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of STAT3 activity delays obesity-induced thyroid carcinogenesis in a mouse model.
Park JW; Han CR; Zhao L; Willingham MC; Cheng SY
Endocr Relat Cancer; 2016 Jan; 23(1):53-63. PubMed ID: 26552408
[TBL] [Abstract][Full Text] [Related]
10. A tumor suppressor role for thyroid hormone beta receptor in a mouse model of thyroid carcinogenesis.
Kato Y; Ying H; Willingham MC; Cheng SY
Endocrinology; 2004 Oct; 145(10):4430-8. PubMed ID: 15231697
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional telomere dynamics in follicular thyroid cancer.
Wark L; Danescu A; Natarajan S; Zhu X; Cheng SY; Hombach-Klonisch S; Mai S; Klonisch T
Thyroid; 2014 Feb; 24(2):296-304. PubMed ID: 23819464
[TBL] [Abstract][Full Text] [Related]
12. An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis.
Furumoto H; Ying H; Chandramouli GV; Zhao L; Walker RL; Meltzer PS; Willingham MC; Cheng SY
Mol Cell Biol; 2005 Jan; 25(1):124-35. PubMed ID: 15601836
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic Actions of the Nuclear Receptor Corepressor (NCOR1) in a Mouse Model of Thyroid Cancer.
Fozzatti L; Park JW; Zhao L; Willingham MC; Cheng SY
PLoS One; 2013; 8(6):e67954. PubMed ID: 23840792
[TBL] [Abstract][Full Text] [Related]
14. SAHA-induced loss of tumor suppressor Pten gene promotes thyroid carcinogenesis in a mouse model.
Zhu X; Kim DW; Zhao L; Willingham MC; Cheng SY
Endocr Relat Cancer; 2016 Jul; 23(7):521-33. PubMed ID: 27267120
[TBL] [Abstract][Full Text] [Related]
15. Reactivation of the silenced thyroid hormone receptor β gene expression delays thyroid tumor progression.
Kim WG; Zhu X; Kim DW; Zhang L; Kebebew E; Cheng SY
Endocrinology; 2013 Jan; 154(1):25-35. PubMed ID: 23183175
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer.
Furuya F; Lu C; Willingham MC; Cheng SY
Carcinogenesis; 2007 Dec; 28(12):2451-8. PubMed ID: 17660507
[TBL] [Abstract][Full Text] [Related]
17. Extranuclear signaling of mutated thyroid hormone receptors in promoting metastatic spread in thyroid carcinogenesis.
Lu C; Cheng SY
Steroids; 2011 Aug; 76(9):885-91. PubMed ID: 21473875
[TBL] [Abstract][Full Text] [Related]
18. Thyroid hormone receptor β sumoylation is required for thyrotropin regulation and thyroid hormone production.
Ke S; Liu YY; Karthikraj R; Kannan K; Jiang J; Abe K; Milanesi A; Brent GA
JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34237030
[TBL] [Abstract][Full Text] [Related]
19. KRAS(G12D)-mediated oncogenic transformation of thyroid follicular cells requires long-term TSH stimulation and is regulated by SPRY1.
Zou M; Baitei EY; Al-Rijjal RA; Parhar RS; Al-Mohanna FA; Kimura S; Pritchard C; BinEssa H; Alanazi AA; Alzahrani AS; Akhtar M; Assiri AM; Meyer BF; Shi Y
Lab Invest; 2015 Nov; 95(11):1269-77. PubMed ID: 26146959
[TBL] [Abstract][Full Text] [Related]
20. Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone beta receptor.
Furuya F; Hanover JA; Cheng SY
Proc Natl Acad Sci U S A; 2006 Feb; 103(6):1780-5. PubMed ID: 16446424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]